NeuroPace
NPCE13.64010.91% ( -1.670 )
NeuroPace (NPCE)
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that deliv...
- Open
- 14.600
- High
- 14.940
- Low
- 13.420
- Prev. Close
- 15.310
- Volume
- 366.17K
- Turnover
- 5.12M
- Avg Price
- 13.975
- Bid/Ask Ratio
- --
- Amplitude
- 9.93%
- 52wk High
- 19.600
- Volume Ratio
- 1.16
- Turnover Ratio
- 1.57%
NeuroPace Analyst Rating
View MoreForecast & Rating
Jul 29, 2026Price forecast
$20.2248.26%
Forecast & RatingStrong buy
9analysts
- Strong buy88.89%
- Buy11.11%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 10 hours ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- MorningStar · 23 hours ago
NeuroPace's Panel Track Supplement Not Approvable in Current Form, FDA Says
- benzinga_article · 1 day ago, 04:06 PM
12 Health Care Stocks Moving In Tuesday's After-Market Session
- PUBT · 1 day ago, 03:33 PM
NeuroPace says FDA deems epilepsy label expansion filing not approvable in current form
- Market Beat · Jul 14 at 01:00 PM
NeuroPace (NASDAQ:NPCE) Shares Down 5.8% - What's Next?
- Global Report · Jul 9 at 09:02 PM
Beyond Big Tech: 10 Under-the-Radar US Stocks Making Moves This Week
